DB:NMI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Aladdin Healthcare Technologies

Executive Summary

Aladdin Healthcare Technologies SE, through its subsidiary, develops a system landscape in which health information stored and managed.


Snowflake Analysis

Worrying balance sheet with weak fundamentals.

Share Price & News

How has Aladdin Healthcare Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NMI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-1.9%

NMI

0.9%

DE Healthcare Services

3.1%

DE Market


1 Year Return

-76.6%

NMI

43.1%

DE Healthcare Services

14.0%

DE Market

Return vs Industry: NMI underperformed the German Healthcare Services industry which returned 43.1% over the past year.

Return vs Market: NMI underperformed the German Market which returned 14% over the past year.


Shareholder returns

NMIIndustryMarket
7 Day-1.9%0.9%3.1%
30 Day33.3%9.9%2.3%
90 Day46.2%11.6%18.4%
1 Year-76.4%-76.6%44.0%43.1%16.5%14.0%
3 Yearn/a59.6%55.8%7.4%-1.2%
5 Yearn/a173.4%161.9%23.8%7.2%

Price Volatility Vs. Market

How volatile is Aladdin Healthcare Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Aladdin Healthcare Technologies undervalued compared to its fair value and its price relative to the market?

5.82x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate NMI's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate NMI's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: NMI is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.

PE vs Market: NMI is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NMI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NMI is overvalued based on its PB Ratio (5.8x) compared to the DE Healthcare Services industry average (3.6x).


Next Steps

Future Growth

How is Aladdin Healthcare Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aladdin Healthcare Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Aladdin Healthcare Technologies performed over the past 5 years?

29.3%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: NMI is currently unprofitable.

Growing Profit Margin: NMI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if NMI's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare NMI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NMI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-10.8%).


Return on Equity

High ROE: NMI has a negative Return on Equity (-67.96%), as it is currently unprofitable.


Next Steps

Financial Health

How is Aladdin Healthcare Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: NMI's short term assets (€341.2K) do not cover its short term liabilities (€1.9M).

Long Term Liabilities: NMI has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: NMI's debt to equity ratio (42.5%) is considered high.

Reducing Debt: Insufficient data to determine if NMI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if NMI has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if NMI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Aladdin Healthcare Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NMI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NMI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NMI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NMI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NMI's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average board tenure


CEO

Wade Menpes-Smith

no data

Tenure

Mr. Wade Menpes-Smith serves as Chief Executive Officer, Managing Director & Chairman of the Board of Directors at Aladdin Healthcare Technologies SE (formerly known as Aladdin Blockchain Technologies Hold ...


Board Members

NamePositionTenureCompensationOwnership
Wade Menpes-Smith
Chairman of the Boardno datano datano data
Bimal Shah
Deputy Chairman & COOno datano datano data
Hamish Badenoch
CFO & Directorno datano datano data
Evandro Fang
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Jon Storm-Mathisen
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Linda Bergersen
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Hilde Nilsen
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Henrik Schirmer
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Guang Yang
Member of Scientific & Medical Advisory Board1.58yrsno datano data
Geir Selbæk
Scientific and Medical Advisory Board Member0.67yrno datano data

1.6yrs

Average Tenure

Experienced Board: NMI's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Aladdin Healthcare Technologies SE's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Aladdin Healthcare Technologies SE
  • Ticker: NMI
  • Exchange: DB
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €17.290m
  • Shares outstanding: 11.45m
  • Website: https://www.aladdinid.com

Number of Employees


Location

  • Aladdin Healthcare Technologies SE
  • Unter den Linden 10
  • Berlin
  • Berlin
  • 10117
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NMIDUSE (Dusseldorf Stock Exchange)YesShare CapitalDEEURApr 2016
NMIDB (Deutsche Boerse AG)YesShare CapitalDEEURApr 2016
NMIXTRA (XETRA Trading Platform)YesShare CapitalDEEURApr 2016

Biography

Aladdin Healthcare Technologies SE, through its subsidiary, develops a system landscape in which health information stored and managed. The company’s solutions include mobile application that allows mercha ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/14 10:53
End of Day Share Price2020/08/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.